Kurzfassung

Studie zur Therapie des Hörsturzes (A two- part, randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety study of SENS-401 in subjects with severe or profound sudden sensorineural hearing loss; Industrie-initiierte Studie)